Down-regulated NEDD4L facilitates tumor progression through activating Notch signaling in lung adenocarcinoma

Liping Lin1,2, Xuan Wu3, Yuanxue Jiang1,2

  • 1Department of Oncology, Panyu Central Hospital, Guangzhou, Guangdong Province, China.

Peerj
|June 1, 2022
PubMed

Insights

Neural precursor cell expressed developmentally down-regulated 4-like protein (NEDD4L) is decreased in lung adenocarcinoma (LUAD), promoting tumor progression by activating Notch signaling. Lower NEDD4L levels correlate with poorer survival in LUAD patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Neural precursor cell expressed developmentally down-regulated 4-like protein (NEDD4L) is an E3 ubiquitin ligase involved in development and tumorigenesis.
  • While NEDD4L's role in lung adenocarcinoma (LUAD) is noted, its precise mechanism in promoting LUAD progression is unclear.

Purpose of the Study:

  • To investigate the role of NEDD4L in LUAD progression and its underlying mechanism.
  • To analyze the correlation between NEDD4L expression and clinical outcomes in LUAD patients.

Main Methods:

  • Analysis of NEDD4L expression in LUAD tissues and cell lines using quantitative real-time PCR (qRT-PCR).
  • Correlation analysis with clinical outcomes using The Cancer Genome Atlas (TCGA) database.
  • In vitro (Cell Counting Kit-8 assay) and in vivo (mouse xenograft) functional studies of NEDD4L in LUAD cell proliferation.
  • Investigation of NEDD4L's effect on Notch receptor 2 (Notch2) stability and Notch signaling pathway activation.

Main Results:

  • NEDD4L expression was significantly decreased in LUAD tissues and cell lines, with lower levels correlating with poorer overall survival.
  • NEDD4L knockdown accelerated LUAD cell proliferation in vitro and tumor growth in vivo, while overexpression inhibited proliferation and tumor growth.
  • NEDD4L reduced Notch2 protein stability via ubiquitination and proteasomal degradation, thereby inhibiting Notch signaling.
  • Notch pathway inhibition counteracted the pro-proliferative effects of NEDD4L knockdown.

Conclusions:

  • Down-regulated NEDD4L facilitates LUAD progression by activating the Notch signaling pathway.
  • NEDD4L acts as a tumor suppressor in LUAD and represents a potential therapeutic target for LUAD treatment.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.0K